Hyperkalaemia induced by carbonic anhydrase inhibitor.

AUTOR(ES)

Wakabayashi, Y

RESUMO

An 81-year-old man developed hyperkalaemic and hyperchloraemic metabolic acidosis following treatment with a carbonic anhydrase inhibitor for his glaucoma. He had mild renal failure and selective aldosterone deficiency was confirmed. In this case the treatment did not lead to hypokalaemia because of the limited potassium secretory capacity in the renal tubules from selective aldosterone deficiency; rather, it may have led to hyperkalaemia because metabolic acidosis induced by the carbonic anhydrase inhibitor caused transcellular movement of potassium.

Documentos Relacionados

• Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
• Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors.
• Inhibition of carcinogen-induced chromosomal aberrations by an anticarcinogenic protease inhibitor.
• Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.
• Mitochondrial carbonic anhydrase.